THEMISMED

Themis Medicare Share Price

₹273.10 +9.15 (3.47%)

05 Nov, 2024 17:32

SIP TrendupStart SIP in THEMISMED

Start SIP

Performance

  • Low
  • ₹262
  • High
  • ₹279
  • 52 Week Low
  • ₹142
  • 52 Week High
  • ₹303
  • Open Price₹264
  • Previous Close₹264
  • Volume133,071

Investment Returns

  • Over 1 Month + 0.68%
  • Over 3 Month + 9.5%
  • Over 6 Month + 26.96%
  • Over 1 Year + 73.18%
SIP Lightning

Smart Investing Starts Here Start SIP with Themis Medicare for Steady Growth!

Themis Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 47.4
  • PEG Ratio
  • 13.8
  • Market Cap Cr
  • 2,514
  • P/B Ratio
  • 6.7
  • Average True Range
  • 13.63
  • EPS
  • 2.7
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -0.7
  • RSI
  • 48.25
  • MFI
  • 28.32

Themis Medicare Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations99.59106.0897.8282.51104.78
Total Income From Operations99.59106.0897.8282.51104.78
P/L Before Interest, Excpt. Items & Tax16.7328.947.365.5411.77
P/L Before Exceptional Items & Tax15.1327.505.202.859.74
P/L After Tax from Ordinary Activities11.1920.313.092.007.10
Net Profit/Loss For the Period9.8718.713.092.007.10
IndicatorMar 24Mar 23
Revenue From Operations [Gross]376.63344.46
Revenue From Operations [Net]376.63344.46
Total Operating Revenues381.76354.32
Total Revenue386.52365.83
Total Expenses351.85306.92
Profit/Loss Before Tax34.6758.91
Profit/Loss For The Period24.7543.29
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity22.0416.07
Net Cash Used In Investing Activity-15.96-23.96
Net Cash Used in Finance Activity-8.770.14
Net Inc/Dec In Cash And Equivalent-2.68-7.75
Cash And Equivalent End Of Year9.8312.51
IndicatorMar 24Mar 23
Total Share Capital9.209.20
Total Non-Current Liabilities34.1735.39
Total Current Liabilities154.52139.07
Total Capital And Liabilities489.97456.29
Total Non-Current Assets195.52190.49
Total Current Assets294.44265.80
Total Assets489.97456.29
Indicator20242023
EBIT Margin (%)11.5319.32
Return On Capital Employed (%)13.1221.58
Return On Equity (%)8.2115.36
Long Term Debt To Equity (%)8.8810.09
Book Value/Share (INR)32.7330.62
IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations117.01122.9997.8282.51104.78
Total Income From Operations117.01122.9997.8282.51104.78
P/L Before Interest, Excpt. Items & Tax15.8127.737.345.5311.77
P/L Before Exceptional Items & Tax13.3725.375.182.859.74
P/L After Tax from Ordinary Activities9.8718.713.072.007.10
Net Profit/Loss For the Period9.8718.713.072.007.10
IndicatorMar 24Mar 23
Revenue From Operations [Gross]376.63344.46
Revenue From Operations [Net]376.63344.46
Total Operating Revenues381.76354.32
Total Revenue386.52365.83
Total Expenses351.88306.93
Profit/Loss Before Tax34.6458.90
Profit/Loss For The Period24.7243.28
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity22.0916.09
Net Cash Used In Investing Activity-15.95-23.96
Net Cash Used in Finance Activity-8.770.14
Net Inc/Dec In Cash And Equivalent-2.62-7.73
Cash And Equivalent End Of Year9.9212.55
IndicatorMar 24Mar 23
Total Share Capital9.209.20
Total Non-Current Liabilities34.1735.39
Total Current Liabilities154.58139.13
Total Capital And Liabilities566.42513.96
Total Non-Current Assets273.25249.43
Total Current Assets293.17264.53
Total Assets566.42513.96
Indicator20242023
EBIT Margin (%)11.5219.32
Return On Capital Employed (%)10.6818.26
Return On Equity (%)11.5216.76
Long Term Debt To Equity (%)7.088.38
Book Value/Share (INR)41.0336.88

Themis Medicare Technicals

EMA & SMA

Current Price
₹273.10
+ 9.15 (3.47%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹266.16
  • 50 Day
  • ₹263.17
  • 100 Day
  • ₹252.37
  • 200 Day
  • ₹233.67

Resistance and Support

261.87 Pivot Speed
  • R3 282.63
  • R2 275.02
  • R1 269.48
  • S1 256.33
  • S2 248.72
  • S3 243.18

Is Themis Medicare Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Themis Medicare Ltd. develops and manufactures pharmaceutical products across segments like anti-infectives, pain management, and critical care. With 3 manufacturing facilities, it serves over 40 countries, offering innovative therapies for a wide range of medical needs. Themis Medicare has an operating revenue of Rs. 420.33 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 9% is okay, ROE of 11% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 31% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 79 which is a FAIR score but needs to improve its earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Themis Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-25 Quarterly Results
2024-07-26 Quarterly Results
2024-05-14 Audited Results & Final Dividend
2024-02-10 Quarterly Results
2023-11-04 Quarterly Results
Date Purpose Remarks
2023-10-10 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Themis Medicare F&O

Themis Medicare Shareholding Pattern

67.15%
0%
0.1%
0.01%
23.65%
9.09%
  • NSE Symbol
  • THEMISMED
  • BSE Symbol
  • 530199
  • Managing Director & CEO
  • Dr. Sachin D Patel
  • ISIN
  • INE083B01024

Themis Medicare FAQs

Themis Medicare share price is ₹273 As on 05 November, 2024 | 17:18

The Market Cap of Themis Medicare is ₹2513.6 Cr As on 05 November, 2024 | 17:18

The P/E ratio of Themis Medicare is 47.4 As on 05 November, 2024 | 17:18

The PB ratio of Themis Medicare is 6.7 As on 05 November, 2024 | 17:18

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form